Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Jump to

    • Hope to get housing finance licence in the near future: Ajay Piramal

    • Piramal has enough cash for acquisitions, expects 15-20% growth

    • Note ban impact on realty not as bad as projected: Ajay Piramal

    • Demerger of pharma, financial srvs biz to take 2 years: Piramal

    • NCL Industries exits CDR; plans to expand cement business

    • 'Will look at Lafarge only if it makes strategic sense'

    • Aim to be among top 3 cos in OTC drugs: Piramal Enterprises

    • Baby care brand will add 8-10% to topline growth: Piramal

    • Piramal, Canada's CPPIB form $500mn realty investment fund

    • Strong growth in Indian telecom to continue: Ajay Piramal

      Chairman of Piramal Healthcare, Ajay Piramal says that the Indian telecom story is still very positive and the growth is likely to continue.

    • Deal with Eli Lilly, Merck on track: Piramal Healthcare

      Swati Piramal, director of Piramal Healthcare tells CNBC-TV18 that it is one of the few pharma companies which are pushing for drug discovery.

    • Exit guaranteed from Vodafone irrespective of IPO: Piramal

      Piramal Healthcare has planned to picked up a 5.5% stake in Vodafone-Essar, valued at about USD 640 million. CNBC-TV18's executive editor Shereen Bhan spoke to chairman of the company, Ajay Piramal on the transaction.

    • Piramal-Vodafone fair deal but core biz worries exist

      In an interview to CNBC-TV18, Vikas Dandekar, India bureau chief of Pharmasianews, says the Pirmal-Vodafone deal is a smart move but the question remains on what happens to the core business. However, he says, over a longer period of time there will be some value accretion.

    • Piramal Glass aims to maintain 25% margins

      Ajay Piramal, Chairman of Piramal Group, in an interview with CNBC-TV18’s Latha Venkatesh and Gautam Broker, gave his perspective of the fourth quarter performance and their divulged future plans.

    • Piramal Healthcare to buy Oxygen Healthcare: PharmaAsia

      Piramal Healthcare is set to buy Ahmedabad-based Oxygen Healthcare, reports CNBC-TV18 quoting Pharma Asia News.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347